A Study on Compliance to Allergen Immunotherapy in Respiratory Allergy
Keywords:
Respiratory allergy, compliance, allergen immunotherapyAbstract
Introduction: Respiratory allergic diseases requires administration of Allergen immunotherapy at frequent intervals for a period of time which is usually 3-5 years which makes compliance issues particularly relevant.
Objectives: To describe socio-demographic profile of study subjects and to assess various factors influencing compliance to allergen immunotherapy.
Methods: A prospective longitudinal study conducted at Allergy clinic, Department of Community Medicine, Kempegowda Institute of Medical Sciences, Bangalore. Data was collected by review of the individual records of all the patients who were started on allergen immunotherapy during January 2011 – December 2014 (3 years). Reason for discontinuation of treatment was collected through phone calls.
Results: There were 109 (53.96%) males and 93 (46.04%) females. Majority i.e. 146 (72.27%) were in the age group of 21- 40 years. There were 117 (57.92%) on allergen Immunotherapy for House dust mite only, 42 (20.79%) for pollen only and 43 (21.29%) for both house dust mite and pollen. 15 (7.43%) subjects have completed 3 years treatment, 125 (60.40%) are continuing treatment and 63 (30.69%) have discontinued treatment (Non-compliance). Commonest reasons for non-compliance were no improvement, afar hospital and adverse reactions.
Conclusion: Non-compliance to allergen immunotherapy was 30.69% and commonest reason for non-compliance was no improvement.
References
Ruby Pawankar, Giorgio Walter Caninica, Stephen T Holgate, Richard F lockey. World Allergy Organization White Book on Allergy 2013 update. Wisconsin (USA): World Allergy Organization p 110-112
Vedanthan PK, Harold Nelson, Shripad N Agashe, Ma-hesh PA, RohitKatial. Textbook of Allergy for the clinician. CRC press, 2014 p 120-124
Calderón MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P. Allergen-specific immunotherapy for respiratory allergies: From meta-analysis to registration and beyond. Journal of Allergy and Clinical Immunology. 2011;127: 30–8.
Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: A practice parameter third update. J Allergy Clin Immunol [Internet]. 2011; 127 (1 SUPPL.):1–55. Available from: http:// dx.doi.org/10.1016/j.jaci.2010.09.034
Lockey RF, Bukantz SC, Bousquet J. Allergens and Allergen Immuno therapy. 2004. 808 p.
Broek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. J Allergy Clin Immunol. 2010;126(3):466–76.
Page PM, Broek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, et al. Global Strategy For Asthma Management and Prevention. Glob Initiat Asthma. 2017; 126(3):http://ginasthma.org/2017-gina-report-global-strat.
Musa F, Al-Ahmad M, Arifhodzic N, Al-Herz W. Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies. Hum Vaccines Immunother. 2017;13(3):514–7.
More DR, Hagan LL. Factors affecting compliance with allergen immunotherapy at a military medical center. Ann Allergy Asthma Immunol [Internet]. 2002;88(4):391–4. Available from: http://dx.doi.org/10.1016/S1081-1206(10)62370-8[Accessed on 2017 June 6]
Incorvaia C, Ridolo E, Puccinelli P, Liuzzo M, Scurati S, Frati F. Patient’s compliance with allergen immuno therapy. 2008;247–52.
Article O, Mahesh PA, Vedanthan PK, Amrutha DH, Giridhar BH, Prabhakar AK. Factors Associated with Non-adherence to Specific Allergen Immunotherapy in Management of Respiratory Allergy. 2009;91–5.
Incorvaia C, Mauro M, Ridolo E, Puccinelli P, Liuzzo M, Scurati S, et al. Patient’s compliance with allergen immunotherapy. Vol. 2, Patient Preference and Adherence. 2008. p. 247–51.
Sánchez J. Adherence to allergen immunotherapy improves when patients choose the route of admini-stration: Subcutaneous or sublingual. Allergol Immuno-pathol (Madr). 2015;43(5):436–41.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
